Is dose escalation of antidepressants a rational strategy after a medium???dose treatment has failed?, European Archives of Psychiatry and Clinical Neuroscience, vol.19, issue.6, pp.387-400, 2005. ,
DOI : 10.1002/cpt1976196795
AccessedFebruary 12, 2017. ,
Placebo-ControlledStudy of Relapse PreventionWithRisperidone Augmentation in Older Patients withResistantDepression ,
Prescriptions s??quentielles??: arguments en faveur d???une modification des sch??mas th??rapeutiques dans les d??pressions r??sistantes, L'Enc??phale, vol.42, issue.1, pp.32-38, 2016. ,
DOI : 10.1016/j.encep.2015.07.008
Triiodothyronine Addition to Paroxetine in the Treatment of Major Depressive Disorder, The Journal of Clinical Endocrinology & Metabolism, vol.89, issue.12, pp.6271-762004, 2004. ,
DOI : 10.1210/jc.2004-1147
Double-Blind, Placebo-Controlled Trial of the Use of Lithium to Augment Antidepressant Medication in Continuation Treatment of Unipolar Major Depression, American Journal of Psychiatry, vol.157, issue.9, pp.1429-1464, 2000. ,
DOI : 10.1176/appi.ajp.157.9.1429
Lithium Augmentation in Treatment-ResistantDepression: Meta- Analysis of Placebo-ControlledStudies, Journal of ClinicalPsychopharmacology, vol.19, issue.5, pp.427-461, 1999. ,
ABSTRACT, CNS Spectrums, vol.154, issue.04, pp.197-206, 2009. ,
DOI : 10.1192/bjp.154.5.672
Combination of Antidepressant Medications From Treatment Initiation for Major Depressive Disorder: A Double-Blind Randomized Study, American Journal of Psychiatry, vol.167, issue.3, pp.281-88, 2010. ,
DOI : 10.1176/appi.ajp.2009.09020186
A Double-Blind, Placebo- ControlledStudy of AntidepressantAugementationwith Mirtazapine, BiologicalPsychiatry, vol.51, issue.201, pp.183-88, 2002. ,
PsychologicalAutopsyStudies of Suicide: A SystematicReview, PsychologicalMedicine, vol.33, issue.3, pp.395-405, 2003. ,
Lifetime Rates of Suicide AttemptsamongSubjectswithBipolar and UnipolarDisorders Relative to SubjectswithOther Axis I Disorders, BiologicalPsychiatry, vol.39, issue.10, pp.896-99, 1996. ,
Sertraline versus OtherAntidepressive Agents for Depression, Cochrane Database of SystematicReviews, 2009. ,
DOI : 10.1002/14651858.cd006117.pub4
URL : http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD006117.pub4/pdf
Lithium in the Prevention of Suicidal Behavior and All-Cause Mortality in Patients With Mood Disorders: A Systematic Review of Randomized Trials, American Journal of Psychiatry, vol.162, issue.10, pp.1805-1824, 2005. ,
DOI : 10.1176/appi.ajp.162.10.1805
Escitalopram versus OtherAntidepressive Agents for Depression, Cochrane Database of SystematicReviews, 2009. ,
DOI : 10.1002/14651858.cd006532.pub2
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164382/pdf
Lithium versus Antidepressants in the Long-TermTreatment of Unipolar Affective Disorder, Cochrane Database of SystematicReviews, 2006. ,
Combined Treatment With Sertraline and Liothyronine in Major Depression, Archives of General Psychiatry, vol.64, issue.6, pp.679-88, 2007. ,
DOI : 10.1001/archpsyc.64.6.679
URL : http://archpsyc.jamanetwork.com/data/journals/psych/11844/yoa60092_679_688.pdf
Efficacy and Safety of TriiodothyronineSupplementation in Patients with Major DepressiveDisorderTreatedwithSpecificSerotoninReuptakeInhibitors, The International Journal of Neuropsychopharmacology, vol.11, issue.05, 2008. ,
Acceleration and Augmentation of AntidepressantsWith Lithium for DepressiveDisorders:Two Meta-Analyses of Randomized, Placebo-Controlled Trials, The Journal of ClinicalPsychiatry, vol.68, issue.06, pp.935-975, 2007. ,
D??pression r??sistante??: les strat??gies de potentialisation, La Presse M??dicale, vol.45, issue.3, pp.338-387, 2016. ,
DOI : 10.1016/j.lpm.2016.02.004
AccessedFebruary 12, 2017. ,
A Pilot Study of the Efficacy and Safety of Paroxetine AugmentedWithRisperidone, Valproate, Buspirone, Trazodone, or Thyroid Hormone in AdultChinese Patients WithTreatment-Resistant Major Depression, Journal of ClinicalPsychopharmacology, 2011. ,
BenefitsfromMianserin Augmentation of Fluoxetine in Patients with Major Depression Non-Responders to ,
Mianserin Augmentation of Fluoxetine, Acta PsychiatricaScandinavica, vol.103, issue.1, pp.66-72, 2008. ,
Use of antidepressant combinations: which, when and why? Results of a Spanish survey, Acta Psychiatrica Scandinavica, vol.64, issue.1, pp.32-35, 2005. ,
DOI : 10.1016/S0197-2456(03)00112-0
A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder, International Clinical Psychopharmacology, vol.23, issue.5, pp.269-75, 2008. ,
DOI : 10.1097/YIC.0b013e328301a74c
Prefrontal repetitive transcranial magnetic stimulation as add on treatment in depression, Journal of Neurology, Neurosurgery & Psychiatry, vol.71, issue.4, pp.546-594, 2001. ,
DOI : 10.1136/jnnp.71.4.546
The Combination of Triiodothyronine (T3) and Sertraline Is Not Superior to Sertraline Monotherapy in the Treatment of Major DepressiveDisorder, Journal of PsychiatricResearch, vol.46, issue.11, pp.1406-1419, 2012. ,
Lithium augmentation in antidepressant-resistant patients, The British Journal of Psychiatry, vol.161, issue.1, pp.128-157, 1992. ,
DOI : 10.1192/bjp.161.1.128b
Beyond the Evidence: Is There a Place for AntidepressantCombinations in the Pharmacotherapy of Depression, The Medical Journal of Australia, vol.187, issue.3, pp.198-199, 2007. ,
A Double-Blind ShamControlledStudy of Right PrefrontalRepetitiveTranscranialMagnetic Stimulation (rTMS):Therapeutic and Cognitive Effect in Medication Free UnipolarDepressionduring 4 Weeks, Progress in Neuro-Psychopharmacology&BiologicalPsychiatry, pp.126-156, 2006. ,
A Placebo-Controlled Comparison of Lithium and Triiodothyronine Augmentation of Tricyclic Antidepressants in Unipolar Refractory Depression, Archives of General Psychiatry, vol.50, issue.5, pp.387-93, 1993. ,
DOI : 10.1001/archpsyc.1993.01820170065008
Lithium and Triiodothyronine Augmentation of Antidepressants, The Canadian Journal of Psychiatry, vol.50, issue.12, pp.791-93, 2006. ,
DOI : 10.1001/archpsyc.1993.01820170065008
Relief of Expressed Suicidal Intent by ECT: A Consortium for Research in ECT Study, American Journal of Psychiatry, vol.162, issue.5, pp.977-82, 2005. ,
DOI : 10.1176/appi.ajp.162.5.977
Escitalopram in the Treatment of Major DepressiveDisorder: A Meta-Analysis, CurrentMedicalResearch and Opinion, vol.25, issue.1, pp.161-75, 2009. ,
Canadian Network for Mood and AnxietyTreatments (CANMAT) Clinical Guidelines for the Management of Major DepressiveDisorder in Adults, Journal of Affective Disorders, vol.117, 2009. ,
TherapeuticEfficacy of Right Prefrontal Slow RepetitiveTranscranialMagnetic Stimulation in Major Depression: A Double-Blind ControlledStudy, Archives of General Psychiatry, vol.56, issue.4, pp.315-335, 1999. ,
Second-GenerationAntipsychotics for Major DepressiveDisorder and Dysthymia, Cochrane Database of SystematicReviews ,
DOI : 10.1002/14651858.cd008121.pub2
Amisulpride versus imipramine and placebo in dysthymia and major depression, Journal of Affective Disorders, vol.43, issue.2, pp.95-103, 1997. ,
DOI : 10.1016/S0165-0327(96)00103-6
Recommandations fran??aises sur l???utilisation de la stimulation magn??tique transcr??nienne r??p??titive (rTMS)??: r??gles de s??curit?? et indications th??rapeutiques, Neurophysiologie Clinique/Clinical Neurophysiology, vol.41, issue.5-6, pp.221-95, 2011. ,
DOI : 10.1016/j.neucli.2011.10.062
Risperidone for Treatment-Refractory Major DepressiveDisorder: A Randomized Trial, Annals of InternalMedicine, vol.147, issue.9, pp.593-602, 2007. ,
The Efficacy and Safety of Aripiprazole as AdjunctiveTherapy in Major DepressiveDisorder: A Second Multicenter, Randomized, Double-Blind, Placebo- ControlledStudy, Journal of ClinicalPsychopharmacology, vol.28, issue.2, pp.156-65, 2008. ,
AccessedFebruary 10, 2017. ,
Strategies for Managing Depression Refractory to Selective Serotonin Reuptake Inhibitor Treatment: A Survey of Clinicians, The Canadian Journal of Psychiatry, vol.43, issue.5, pp.476-81, 2000. ,
DOI : 10.1016/S0006-3223(98)90777-6
Which antidepressants have demonstrated superior efficacy? A review of the evidence, International Clinical Psychopharmacology, vol.22, issue.6, pp.323-352, 2007. ,
DOI : 10.1097/YIC.0b013e3282eff7e0
Properties of urophysial proteins (urophysins) from the white sucker, Catostomus commersoni, Molecular and Cellular Endocrinology, vol.3, issue.4, pp.297-307, 1975. ,
DOI : 10.1016/0303-7207(75)90011-8
ComprehensiveAnalysis of Remission (COMPARE) with Venlafaxine versus SSRIs, BiologicalPsychiatry, vol.63, issue.4, pp.424-458, 2008. ,
DOI : 10.1016/j.biopsych.2007.06.027
Efficacy and Safety of TranscranialMagnetic Stimulation in the Acute Treatment of Major Depression: A MultisiteRandomizedControlled Trial, BiologicalPsychiatry, vol.62, issue.11, pp.1208-1224, 2007. ,
Excess Mortality in Bipolar and Unipolar Disorder in Sweden, Archives of General Psychiatry, vol.58, issue.9, pp.844-50, 2001. ,
DOI : 10.1001/archpsyc.58.9.844
Recommandations françaises sur l'utilisation de la stimulation magnétique transcrânienne répétitive (rTMS): règles de sécurité et indications thérapeutiques, 2011. ,
Efficacy of Risperidone Augmentation to Antidepressants in the Management of Suicidality in Major DepressiveDisorder: A Randomized, Double-Blind, Placebo- Controlled Pilot Study, The Journal of ClinicalPsychiatry, vol.69, issue.8, pp.1228-1264, 2008. ,
A comparison of paroxetine and amisulpride in the treatment of dysthymic disorder, Journal of Affective Disorders, vol.70, issue.3, pp.313-330, 2002. ,
DOI : 10.1016/S0165-0327(01)00327-5
Acute and Long-TermOutcomes of a Single- Blind RandomizedStudy, CombiningMedications to EnhanceDepressionOutcomes (CO-MED American Journal of Psychiatry, vol.168, issue.7, pp.689-701, 2011. ,
Amisulpride versus Fluoxetine in Patients withDysthymia or Major Depression in Partial Remission A Double-Blind, Comparative Study, Journal of Affective Disorders, vol.4897, issue.1, pp.47-56, 1998. ,
Compared with fluoxetine monotherapy, mirtazapine plus venlafaxine or fluoxetine increase remission but not response in patients with major depressive disorder, Evidence-Based Mental Health, vol.13, issue.3, pp.83-83, 2010. ,
DOI : 10.1136/ebmh1061
Medication Augmentation after the Failure of SSRIs for Depression, New England Journal of Medicine, vol.354, issue.12, pp.1243-5210, 1056. ,
DOI : 10.1056/NEJMoa052964
Furukawa, and Multiple Meta-Analyses of New GenerationAntidepressants (MANGA) Study Group Mirtazapine versus OtherAntidepressants in the Acute-Phase Treatment of Adultswith Major Depression:SystematicReview and Meta-Analysis, The Journal of ClinicalPsychiatry, vol.69, issue.9, pp.1404-1419, 2008. ,